4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
BioDlink International Company Limited (1875) operates in the Biotechnology industry and is headquartered in Suzhou, China with about 579 employees. Its market capitalization is roughly CNY 3 billion. In the fiscal year ended 2025-12-31, 1875 reported CNY 748M in revenue and (CNY 100M) in net income.
BioDlink International Company Limited, an investment holding company, engages in the research, development, manufacturing, and marketing of anti-tumor drugs in Mainland China and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 748M | CNY 1.1B | CNY 781M | CNY 442M | — |
| Gross Profit | CNY 389M | CNY 782M | CNY 574M | CNY 371M | — |
| Operating Income (EBIT) | (CNY 81M) | CNY 37M | (CNY 21M) | (CNY 39M) | — |
| Net Income | (CNY 100M) | CNY 35M | (CNY 38M) | (CNY 50M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 1.3B | CNY 1.5B | CNY 1.4B | CNY 1.3B | — |
| Total Liabilities | CNY 634M | CNY 779M | CNY 739M | CNY 547M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1875 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms